Splenic B-cell Lymphoma with Prominent Nucleoli
📧 Sign up to get email alerts when something new happens for Splenic B-cell Lymphoma with Prominent Nucleoli.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Zanubrutinib, Obinutuzumab, and Lenalidomide (ZGR) in the Treatment of Newly Diagnosed Splenic B-cell Lymphoma With Prominent Nucleoli (SBLPN): A Prospective, Open-label, Single-arm Clinical Trial [Phase 2]
A Phase 2, open-label, single-arm trial evaluating Zanubrutinib, Obinutuzumab, and Lenalidomide (ZGR) for newly diagnosed Splenic B-cell Lym…